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A. Abstract
This study compared awareness of and attitudes toward celiac disease (CD) among American
and Italian medical professionals, patients, and the general public in order to better understand and
identify barriers to celiac disease diagnosis and patient wellbeing in the United States. Although the
U.S. prevalence of the disease is somewhat higher than in Italy, the rate of diagnosis in the United
States is significantly lower. One of the biggest differences between the two countries is awareness
level (Guandalini, 2012 & Fasano, 2001). Factors that impact awareness are an important topic for
study because of the strong relationship between awareness level and successful celiac disease
diagnosis. Untreated celiac disease is associated with reduced quality of life and increased healthcare
costs (Biagi, 2010 & Hershcovici, 2010). In addition, screening for celiac disease is inexpensive and
reliable treatment is readily available (Reddick, 2006). The main issue in the United States in under
diagnosing celiac disease is awareness of medical professionals and the public.
The topic of how awareness level as well as social and medical support systems affect celiac
disease diagnosis and wellbeing of patients with celiac disease in the United States and Italy was
investigated by interviewing patients and celiac disease professionals from the two countries and
comparing their perspectives. Data were also collected through social observation, visiting stores and
restaurants that provided gluten-free products, and comparing information provided by awareness
organizations from each country. Lack of awareness among both patients and medical professionals,
the social environment surrounding celiac patients, and a lack of governmental regulation for the
gluten-free food industry all proved to be significant barriers to patients with celiac disease in the United
States. Fully identifying these barriers is the first step to addressing the issue of celiac under-diagnosis
in the U.S. and will facilitate the development of more effective and efficient solutions.
B. Glossary/Abbreviations
AIC: Associazione Italiana Celiachia (Italian Celiac Disease Association)
CD: Celiac disease
CDF: Celiac Disease Foundation
EGD: Esophagogastroduodenoscopy
GF: Gluten-free
-

GFD: Gluten-free diet
NDDIC: National Digestive Diseases Information Clearinghouse
PPM: Parts per million

C. List of tables/figures
Table 1. Top Barriers Identified to Patient Diagnosis and Wellbeing
Table 2. Top Solutions Discussed during Interviews

4

D. Table of contents
A. Abstract
B. Glossary/Abbreviations
C. List of tables/figures
D. Table of contents
E. Introduction
F. Literature review
G. Data and methods
H. Results
I. Discussion
J. Lessons learned & Conclusion
K. References
E. Introduction
Celiac disease (CD) is a genetically-linked digestive disorder where the lining of the small
intestine is damaged by an autoimmune reaction when gluten is ingested (Nelson, 2002). Gluten is a
protein found in all grains of the wheat family (NDDIC, 2008). Although medical professionals from
around the world once believed celiac disease was extremely rare, it has been proven that this is not
the case. CD affects nearly 1% of the general U.S. population (Guandalini, 2012 and Fasano, 2001).
Although the disease itself is not rare, successful and timely diagnosis of CD in the United States is
very uncommon. According to a large national screening study, CD affects 1 out of every 133
Americans. However, only 1 out of every 4,700 Americans with CD is diagnosed. This means that out
of the estimated 3 million cases in the country, only about 3% of them are diagnosed, leaving the rest
undiagnosed and untreated (University of Chicago Medical Center, 2003).
The research conducted during this project explored the previously unstudied topic of how
awareness level and social support system affect celiac disease diagnosis and wellbeing of patients
with celiac disease (CD) in the United States and Italy. The goals of this project were a) to gain a better
understanding of how awareness and attitudes of medical professionals and the public affect celiac
disease diagnosis b) to identify barriers to timely diagnosis and treatment of celiac disease that patients
with CD encounter in both countries and c) to discover possible ways for the United States to improve
current awareness programs. The hypothesis was that lack of awareness and social treatment of celiac
disease would prove to be significant barriers to patients with CD in the United States.
F. Literature Review
The under-diagnosis of celiac disease in the U.S. is a major cause for concern for professionals
and patients alike because of the damage to patient health and quality of life associated with untreated
CD. Because this disease damages the small intestine lining, nutrient malabsorption is a major problem
in untreated cases. Long-term complications in uncaught celiac cases may include delayed growth and
short stature in children, and osteoporosis, arthritis, seizures, infertility, recurrent miscarriages, irondeficiency anemia, depression, and intestinal cancers in adults (NIH, 2008). A strict gluten-free diet is
currently the only treatment for CD and some studies have shown that overall mortality in celiacs not on
the therapeutic diet is 4.5 - 6 times higher than the average rate (Biagi, 2010).
Having a low rate of CD diagnosis in the United States is also costly from a financial standpoint.
Overall, healthier patients lead to lower healthcare costs. Currently, fast, inexpensive, and accurate
screening technology is available, around 50$ a blood test (Reddick, 2006). While Americans are not
routinely screened for CD (NIH, 2008), there are currently a growing number of medical professionals
who support a mass screening approach. One study has shown through statistical models that if the
time-delay from onset to diagnosis is longer than 6 years, then a mass screening approach is a more
cost-effective method for diagnosing CD than using an individual case-finding method alone
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(Hershcovici, 2010). The current disease onset to diagnosis delay time in the United States is an
average of 11 years (University of Chicago Medical Center, 2003).
Another significant factor in favor of pursuing increased celiac disease diagnosis in the United
States is that there is also an effective and known treatment available. After a patient has undergone an
intestinal biopsy to confirm the disease, treatment consists of a strict and life-long gluten-free diet
(GFD) and patient health improvement can begin within days (NIH, 2008). Some studies have shown
that the previously elevated mortality rate of patients who follow a strict GFD returns to that of the
general population after some time (Biagi, 2010).
The final reason why increased celiac disease diagnosis should be aggressively pursued within
the United States is the sheer potential for what we can learn as researchers and healthcare
professionals. The greater the number of patients that are diagnosed, the greater the number of cases
we have to learn from. Celiac disease is the only autoimmune disease with a clearly identified trigger,
gluten, making it a good model to study other autoimmune diseases (University of Chicago Medical
Center). CD also has strong links to multiple other autoimmune disorders, such as type 1 diabetes and
rheumatoid arthritis. There is growing evidence showing genetic connections between these diseases,
but it is still an area about which science understands very little (NIH, 2008).
There are a few different factors believed to be behind the under-diagnosis of CD in the United
States, but they all lead back to awareness and education. One of the challenges of diagnosing CD is
that it can be tricky to notice if a doctor is not specifically looking for it. However, the screening tests
make this condition easy to detect once suspected. An inaccurate but still prevalent perception among
many U.S. physicians that CD is rare is one possible explanation for under-diagnosis (Hamilton, 2005).
Another factor involved in this issue is that celiac disease is a chameleon. It comes in multiple forms
and the disease presentation is different depending on life-stage. In addition, many of the classic
symptoms of CD can easily be attributed to other conditions. It is not uncommon for individuals who
have CD may also have other disorders that distract from CD diagnosis (Pruessner, 1998; Catassi,
2008). The lack of physician education and the misconceptions surrounding this disorder hinder the
successful diagnosis of celiac disease in the United States (Zipser, 2005), making proper education and
increased awareness a significant need. The awareness issue is not isolated to the medical profession
however; it also extends to the United States general population. Currently, there are a few major
awareness campaigns and many smaller organizations in the United States slowly gaining ground, but
there is still a long way to go in this movement (NIH News, 2006 and Celiac Disease Foundation, 2011).
Much can be learned by studying how Italy approaches celiac disease. Italy is an excellent
country for comparative study because of its similarities to the U.S. in disease prevalence and testing
techniques. Based on screening data, the prevalence of the disease is similar in the two countries,
about 1:184 people in Italy (Fasano, 2001), while the U.S. CD prevalence is slightly higher, between
1:133 to 1:111 people (Guandalini, 2012 and Fasano, 2001). The screening tests and diagnostic criteria
used are also the same in both countries (NIH, 2008 and Ministero Della Salute, 2008). The United
States can learn from Italy concerning celiac disease because of the multiple things that Italy does
differently that affect its diagnosis rate. According to screening studies, the Italian ratio of known cases
to unknown cases is 1:7 (Fasano 2001) and the U.S. ratio of known to unknown cases is about 1:33
(University of Chicago Medical Center, 2003).
Italy’s national screening system is a major factor that influences its approach to CD. In this
program, all children are screened before the age of 6 (Mahnke, 2007) and then anyone who tests
negatively after the initial screening is re-screened if they begin to show symptoms and CD is
suspected by a specialist (Ministero Della Salute, 2008). Under Italy’s universal health care system
(Maio, 2002), the cost for all documented celiac-related medical care and testing, as well as a monthly
stipend to pay for gluten-free food products is covered by the government (Ministero Della Salute, 2008
and Associazione Italiana Celiachia). In the U.S., there is neither a national universal insurance
program nor a government screening program in place. Although the government recommends
screening of symptomatic individuals, those having other autoimmune disorders or first and second
degree relatives of diagnosed celiacs (National Consensus Development Program, 2004), insurance
coverage for CD care and testing in the United States is inconsistent and complicated. Coverage differs
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greatly between providers (Atlantic Health System). The lack of reliable coverage in the U.S. is a major
issue because while the screening for celiac disease is inexpensive, the intestinal biopsy required to
confirm the diagnosis is not. This procedure normally ranges between $2000 and $3000, which is outof-reach for many patients without insurance coverage (New Choice Health Medical Cost Comparison,
2010). There is also no coverage in the United States for the added expense of gluten-free products
and some of them cost almost as much as their gluten counterparts (Alderman, 2009).
G. Methods
Project Hypothesis
Lack of social and professional awareness will prove to pose significant barriers to timely and
effective celiac disease diagnosis and treatment in the United States.
Study design
This project was designed with 3 main goals at the forefront: 1) to better understand how
awareness and attitudes of medical professionals and the public affect celiac disease diagnosis 2) to
identify barriers to timely diagnosis and treatment of celiac disease that patients with CD encounter in
both countries and 3) to discover possible ways for the United States to improve its current awareness
efforts.
Data were collected through literature analysis, cultural and social observation, and
interviewing. Semi-structured interviews lasting 30-60 minutes were conducted with one adult and
pediatric patient from each country, a dietitian and an awareness organization representative from each
country, and a U.S. primary care provider, and two Italian gastroenterologists. This research was done
in part with the help of a translator who translated all consent/assent forms and recruiting documents
into Italian. The primary investigator contacted celiac disease centers (University of Chicago Celiac
Disease Center in the U.S.), hospitals (Policlinico, Sacco, and Humanitas hospitals in Milan), and
awareness organizations (Celiac Disease Foundation in the U.S. and Italian Celiac Association
Lombardia in Milan) by phone or email and provided informational letters to recruit medical
professionals and awareness organizations. Celiac patients were given informational letters by their
medical doctor or celiac awareness organization and requested to contact the primary investigator if
they were interested in participating in the study. Recruitment letters in Italy were also distributed to
English for Business class participants by an American celiac contact of the primary investigator.
Sessions began with each interviewee being requested to fill out a questionnaire concerning his/
her opinions about perceived prevalence and awareness of CD among professionals and public.
Interview questions related to attitude barriers, and methods for diagnosing and coping with celiac
disease. No identifiable information was collected or stored and all possible precautionary measures
were taken to protect the privacy and confidentiality of the interviewed patients.
Data were also collected in the form of educational materials from each celiac awareness
organization and digital photographs were taken to document items such as restaurant menus, glutenfree products and stores, awareness brochures, and buildings. Data were evaluated qualitatively using
the interview recordings and completed questionnaires, and educational material provided by the two
awareness organizations, such as brochures and online resources. Analytical techniques included
listening to audio recordings, taking notes, making tables to compare features, and contrasting
awareness organization physical and online resources.
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H. Results
I. Patient Interviews: Barriers to celiac disease diagnosis and patient well-being identified.
One of the most significant barriers to patient wellbeing in both countries proved to be a lack of
effective celiac disease diagnosis. The negative symptoms of celiac disease, when left untreated,
proved to significantly affect patient quality of life pre-diagnosis. Related to this, one of the main barriers
identified for patients in the U.S. was a lack.of awareness and knowledge among medical professionals
about celiac disease. For the U.S. adult patient, who knew almost nothing about CD before her
diagnosis, low awareness among medical professionals led to a delayed diagnosis time and years
without answers. The U.S. adult patient described seeing numerous specialists over a period of multiple
years and feeling tired and frustrated with feeling sick without any explanation. On the other hand, the
Italian patients interviewed were both diagnosed within a matter of months. The adult Italian patient
also described having moderately high awareness of celiac disease before his diagnosis. Although his
was an asymptomatic case; he was diagnosed during routine screening after another family member
was diagnosed.
Another significant barrier to patient wellbeing discovered in the U.S. was a lack of patient
knowledge and education about the gluten-free diet in the months immediately following diagnosis.
Both U.S. patients described that it is very difficult to always completely avoid gluten because of
“hidden” gluten not clearly specified by food labeling and cross-contamination at restaurants. Negative
symptoms that occur upon accidental gluten ingestion continue to be a barrier to patient wellbeing even
after patients become more familiar with the GFD. The Italian patients expressed that the adjustment to
a GFD post-diagnosis was a smooth and supported process.
Shopping also poses a barrier to celiacs in the United States because, in many locations, glutenfree products are only low to moderately accessible and are also more expensive than their glutencontaining counterparts. In Italy, both patients shared that they did not feel limited in any way by the
GFD. Gluten-free products are clearly marked and often widely available even in smaller grocery
stores. Even though gluten-free products are more expensive, celiacs in Italy are provided with a
monthly stipend to offset the additional cost of GF products. One patient shared, in his home city of
Milan, there is a small chain of entirely gluten-free specialty stores.
Barriers to patient wellbeing also proved to be social in the United States. A lack of knowledge
among friends, colleagues, and restaurant staff about the GFD may put celiacs in uncomfortable or
awkward situations where explaining or asserting their needs becomes an unpleasant experience. In
Italy, because celiac disease is such a well-known issue, the Italian patients shared that friends,
coworkers and restaurant staff are very familiar with CD and the needs of a gluten-free diet.
2. Health Care Provider Interviews: Barriers to celiac disease diagnosis and patient well
being identified.
The U.S. primary care provider and a registered dietitian who were interviewed reported that
awareness is easily the biggest barrier to celiac patient diagnosis and wellbeing. Because awareness
is so low, many doctors do not diagnose celiac disease because they are not looking for it, according
to the interviewees. In one U.S. doctor’s opinion, the lack of awareness among medical professionals
is due to a lack of education during medical school. The Italian professionals discussed a similar issue.
While Italy’s approach to CD is strong in the areas of diagnosis and treatment because of the longrunning CD research in this country, one Italian interviewee still reported that an area for significant
improvement included educational unification among medical professionals. He explained that this
disunity currently results in regional differences in diagnosis and treatment. One Italian medical
professional stressed that to improve the diagnostic rates for celiac disease in Italy, it is important that
medical professionals be educated on the importance of not underestimating the signs and symptoms
of celiac disease. She shared that the signs of CD are subtle and diverse, and it is important to be
vigilant. The other Italian clinician shared that he believes Italy’s rate of CD diagnosis is higher than
that of the United States because of greater knowledge and awareness among Italian physicians.
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However, Italian health care professionals also reported that even though there is a greater
awareness of CD in Italy, there are still barriers to overcome. Both clinicians report they believe that
while their colleagues are moderately familiar with CD, the general population of Italy is only slightly
aware of this condition. Like Italy, the U.S. professionals report that the issue of low awareness also
extends to the general population. To raise awareness among the public and food industries, the U.S.
general practitioner interviewed reports that education should start with the people and be consumerdriven. He explained, by educating the public, people will know to ask their health care provider about
CD. He reported this is one of the most impactful things that can be done to improve diagnostic rates
for CD in the U.S.
Even after a patient is diagnosed, the quality of post-diagnosis support greatly varies based on
where the patient lives in the United States, resulting in another possible barrier to patient wellbeing.
Also as reported by one U.S. medical professional, the complications involved in getting insurance
coverage for celiac disease testing are a frequent hurdle to celiac disease diagnosis. All professionals
interviewed agreed that the issue of insurance coverage in the U.S. likely poses barriers to CD
diagnosis and treatment.
Both Italian professionals agreed that the quality of life and post-diagnosis support for celiacs in
Italy is very strong. One physician explained this is largely because of the Italian Celiac Disease
Association’s efforts. While one Italian clinician reported that quality of life for celiacs in Italy is very
good, one of the Italian physicians shared that there is still room for improvement, sharing that one of
the most significant things to improve life for celiacs in Italy would be increased access to GF products
at social events. The U.S. professionals described less favorable conditions for celiacs in their country.
In addition to the medical and diagnostic barriers that celiacs may face, challenges are also
socioemotional, such as the frustration and embarrassment many celiacs face when having to ask
several questions about ingredients or discussing their dietary needs in various social situations.
Talking about dietary needs can be uncomfortable and may draw unwanted attention. Other challenges
reported in the U.S. by medical providers include the higher cost of gluten-free foods, cross
contamination at restaurants, low awareness of restaurant staff, and difficulty reading food labels to find
allergy information.
3. Celiac Awareness Organization Representative Interviews: Barriers to celiac disease
diagnosis and patient well-being identified.
The U.S. celiac disease awareness organization representative also identified under-diagnosis
of celiac disease, related to low awareness in all segments of the U.S. population, as a significant
barrier to patient wellbeing in the United States. She also explained that once patients are diagnosed,
advocacy and support are necessary to enable patients to follow a gluten-free lifestyle, but often
patients do not get the support they need. She reported that other barriers to patient wellbeing and
diagnosis include an overall lack of unity and organization; there is no national database or data
collection system, no screening system in place, and medical education also varies. Many doctors in
the U.S. currently practicing were taught that CD was rare, a common misconception that affects how
medical professionals approach celiac disease. Barriers among medical professionals to celiac
disease diagnosis are mainly in the education category, including an overall lack of knowledge about
CD, gaps in original training and being open to learning new things. The U.S. representative reported
that research into the area of CD is greatly needed and has possible far-reaching implications; CD is
not the only autoimmune disease where the elimination of gluten has beneficial effects, making it an
issue with the potential to influence many.
Because this issue influences many, she reported that much change is needed. She explained
that awareness is crucial and the factors that play the biggest role in awareness levels are funding,
research, and government recognition. She reported that the most significant change that could be
made to address barriers celiac patients face would be Food and Drug Administration regulation of the
term “gluten-free.” Currently, there are no government-regulated standards for the concentration (PPM)
of gluten that can be found in a product for it to still be considered gluten-free.
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She explained that government regulation gives a lot more weight to the cause. This would increase
awareness and customer demand for products. Food industries also would take more interest due to
increased awareness levels. She proposed that an overall increase in awareness would lead to high
diagnostic rates.
Like the medical professionals interviewed, the U.S. representative also agreed post-diagnosis
support is an area that may pose barriers to celiac patients. She explained that CD is unique in that a
patient is essentially cured if he/she follows the GF diet. Often, if a patient starts feeling better, he/she
is much less likely to seek out much follow-up care with his/her health provider. However, she reported
there may be room for improvement in the follow-up care that professionals do provide. She explained
that patients are not always being strongly advised against eating gluten again. Consequently,
“cheating" on the diet is a significant issue for many patients, because of low education about the long
term negative effects of not adhering strictly to the GFD.
The U.S. representative reported that costs of celiac disease diagnosis and treatment may also
be a hurdle in the United States. Although it does exist, insurance coverage is often limited. Initial blood
testing is not expensive, but the biopsy to confirm diagnosis as well as following a GFD long-term is.
Life at home for a celiac is also a little more complicated at first; making sure house is safe, avoiding
cross-contamination, and finding substitutions are some of the challenges. Celiac students also face
many challenges at school and eating out due to low awareness about the GFD.
According to the U.S. representative, Italy has recognized that CD is not rare, and consequently
has a national database and a program for gluten free products on prescription. According to the Italian
representative, the Italy’s national celiac disease association, AIC, (Associazione Italiana Celiachia) is
the main reason why quality of life is so comparable to those without CD in Italy. Through the efforts of
AIC, celiacs are provided with a stipend for gluten-free products, exemption from military service, a
quarterly newspaper, and a network of restaurants educated about celiac disease has been created
throughout the country. AIC also provides many other services to celiacs living in Italy. One of the most
significant is that AIC maintains a listing of and oversees certification for all the companies, restaurants,
and hotels that provide gluten-free products or services. This organization also plays a large role in CD
awareness, through magazine articles about CD, distribution of new research to its members, and
hosting an annual meeting where celiac specialists speak. This event is attended by many doctors and
patients alike. AIC also has a related foundation that supports research. In the United States, the Celiac
Disease Foundation (CDF) is also active in the areas of education and awareness by hosting
conferences, facilitating peer-to-peer medical education, and sponsoring a national awareness
campaign about the symptoms of celiac disease. CDF also plays a role in the areas of advocacy and
support as founding member of the American Celiac Disease Alliance, a legislative lobby in Washington
DC that works with National Institutes of Health, the Food and Drug Administration, and Congress on
celiac-related issues. There are local CDF chapters and support groups in many of the larger cities
around the U.S. CDF also provides a hotline and information packets to patients free of charge, as well
as information for physicians and a quarterly newsletter.
The representative of AIC reported that his organization’s role in the management of celiac
disease is as a voice and presence for celiac issues in the government. Part of this is providing glutenfree products and/or a stipend to patients, making it possible for celiacs to eat in public settings such as
hospitals and universities. It is vital that an individual have the security that they will be able to eat
something even though they are celiac.
He shared the strengths in Italy’s approach to diagnosis and treatment of celiac disease are
because the doctors are very aware of CD and can effectively diagnose patients. Even though his
country’s approach is overall strong, even he reported that there are some doctors with low awareness
and outdated knowledge about CD. Unlike in the past, the difference now is that training is available if a
doctor would like to get it.
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He said that celiac disease awareness associations play the biggest role in celiac disease
awareness levels in a country (especially in Italy), because they can work cooperatively with the
government on behalf of celiacs. Through this, a celiac disease association has the power to influence
government legislation in favor of celiac laws and research, to spread information and news, and to
work closely with contacts in the Ministry of Health. Essentially, AIC is able to work as a united force
across the country to improve training for doctors, care for celiacs, and increase awareness among the
public.
In this interviewee’s opinion, post-diagnosis support is strong for celiacs living in Italy. Celiac
patients, certified by the country’s ministry of health, are eligible to receive a stipend to help offset the
increased cost of gluten-free products. AIC plays a major role in educating new patients about how to
follow a gluten free diet with informational packets. Celiacs can also can get information from the AIC
website. This representative believed that there may be a relationship between improved post
diagnosis celiac support and increased rate of celiac diagnosis. If industries and restaurants are aware
of CD, the public will be more aware, and there will be more help available to guide undiagnosed
patients to a diagnosis. He reported that attitude barriers among medical professionals in Italy to celiac
disease diagnosis are few, if any. The only possible barrier is a lack of knowledge about CD.
He reported that life at home for a celiac in Italy is very simple because there are so many
gluten-free products available, although it was not like this 10 years ago. Today there are many more
resources available to celiacs that there were not a decade ago, including a book of all gluten-free
supermarket products, and free or stipend-available products at pharmacies. In the last decade,
conditions for celiacs in Italy have significantly improved. Life at school for a celiac in Italy is not as
simple. While there is a law that mandates schools to prepare GF meals for celiac students (as in the
United States), it is not always an ideal situation because the celiac option is sometimes very different
from what the other students are eating. In addition, there are people who do not know or understand
the requirements of a GFD, so they may make mistakes in preparing the GF meal. Normally in schools,
the celiac receives the different foods packed in a box with his/ her name and identification number on
it. Sometimes the family brings bread, pasta, or crackers for the student, because the school does not
provide these items. Today, shopping for a celiac in Italy is very simple; gluten-free products can be
widely found at pharmacies, supermarkets, and completely gluten-free stores.
The biggest challenges people with celiac disease face in Italy are involved with eating outside
of the home. Although AIC has 2,000 restaurants across the country certified, there are still many who
do not know about the gluten-free diet and therefore cannot provide high-quality service. For a
restaurant or hotel to be certified, they must go through an AIC education program. They are then
inspected 2 times a year. Certification is voluntary; there is no law obliging restaurants or hotels to
provide gluten-free food in Lombardia, the region Milan is located in. In some regions, there are
regional laws that require restaurants to provide gluten-free meals. In this interviewee’s opinion,
following a gluten-free diet does not generally have strict dietary limitations that significantly impact
quality of life. With so many gluten-free products available, many celiacs do not find the gluten-free diet
to be very restrictive. However, it depends on the person; some people find it harder to change their
habits than others. The gluten-free products are not exactly the same, but they are acceptable. This
interviewee shared that one way to improve life for people with CD in Italy would be to have restaurants
everywhere that can offer a GF meal so then no celiac has to worry about eating away from home.
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4. Restaurant and Grocery visits
Italy:
In the restaurants and ice cream shops (gelaterias) visited, staff members were very
knowledgeable about the ingredients in their products, aware of cross-contamination, and were very
easy to work with. If they were not sure about ingredients (a rare occurence), they quickly and willingly
provided a list of ingredients or a recipe to be inspected. In the chain grocery store visited, products
were clearly marked and easy to find. Even as a relatively small store, a selection of gluten-free
products could be found in the dairy and deli section, in the dry goods section, and in the freezer
section. At the gluten-free speciality store visited, an extremely wide selection of gluten-free items and
brands was available including some fresh and frozen pastry items that were made by the in-store
bakery. The store had multiple locations around Milan.
United States:
In the restaurants and cafes visited in the United States, knowledgeability of staff was in general
very low. While some staff were willing to work to accommodate a gluten-free request, others either
did not have either the knowledge, resources, or willingness to do so. Awareness of the gluten-free diet
and cross-contamination was also low. In the United States, as expressed in the interviews, shopping
for a celiac varies. At one small-town grocery store visited, there were almost no gluten free products,
other than those that were naturally gluten-free. However, there are a growing number of specialty/
health food stores that carry a small selection of GF products, but selection is limited and cost is often
a limiting factor. At one very large grocery store visited, the store had a completely GF aisle and
freezer section. However, this high level of product selection is exceptional for stores in the midwestern
United States.

12

T a b le 1. T o p B a rrie rs Id e n tifie d to P a tie n t D ia g n o s is a n d W e llb e in g in th e U n ite d S ta te s
B y P a tie n ts :

B y M e d ic a l P ro fe s s io n a ls :

B y A w a re n e s s O rg a n iz a tio n
R e p r e s e n ta tiv e s :

• A w a r e n e s s a m o n g m e d ic a l
p ro fe s s io n a ls

•

H e a lth c a re p ro v id e r a w a re n e s s

• N o F D A re g u la tio n o f th e te rm
“ g lu te n - fr e e ”

• G e n e ra l p o p u la tio n a w a re n e s s
• E d u c a tio n a b o u t g lu te n - fr e e d ie t
p o s t-d ia g n o s is
• M e d ic a l e d u c a tio n to id e n tify s u b tle
s ig n s a n d s y m p to m s a s C D

• N o c le a r s ta n d a rd fo r p a rts p e r
m illio n (P P M ) o f g lu te n th a t c a n be
fo u n d in a p ro d u c t to s till be
c o n s id e re d g lu te n -fre e

• N e g a tiv e s y m p to m s th a t o c c u r
u p o n a c c id e n ta l g lu te n - in g e s tio n
• F ru s tr a tio n a n d e m b a r ra s s m e n t o f
e x p la in in g n e e d s fo r c e lia c p a tie n ts
• A w a r e n e s s a m o n g frie n d s ,
c o lle a g u e s , & re s ta u r a n t s ta ff

• U n d e rs ta n d in g o f th e s e rio u s n e s s
th a t a c e lia c m u s t a v o id g lu te n

•

In c o n s is te n t m e d ic a l e d u c a tio n

• In c o n s is te n t p o s t-d ia g n o s is s u p p o r t

• L a c k o f a w a re n e s s a m o n g m e d ic a l
p ro fe s s io n a ls

•

.

In s u ra n c e c o v e ra g e fo r c e lia c
te s tin g

In c o n s is te n t q u a lity o f p o s td ia g n o s is s u p p o r t a n d e d u c a tio n
a b o u t th e g lu te n - fr e e d ie t

• G e n e ra l lo w a c c e s s ib ility o f g lu te n fre e p ro d u c ts

• C r o s s -c o n ta m in a tio n a t re s ta u ra n ts
• L a c k o f r e s e a rc h (a n d a d is trib u tio n
o f re s e a rc h fu n d s )

• T ra v e lin g w ith C D b e c a u s e th e
a v a ila b ility o f G F p ro d u c ts is
in c o n s is te n t

• L o w r e s ta u r a n t s ta ff a w a re n e s s
• L im ite d in s u ra n c e c o v e ra g e
• In c re a s e d s h o p p in g tim e to re a d
la b e ls

•

H ig h e r c o s t o f g lu te n - fre e p ro d u c ts

• C o s t a n d in v a s iv e n e s s o f b io p s y to
c o n firm C D

I. D iscussion
Identifying the barriers to celiac disease diagnosis and treatment in the United States is the first
step to addressing this issue of underdiagnosis and patient wellbeing. Fully identifying the barriers
enables development and implementation of more focused, effective, and cost-efficient solutions.
Long-term outcomes for celiac disease patients depend heavily on whether or not a GFD can
be followed successfully. In some ways, the celiac condition is unique in that if a celiac strictly follows a
GFD, they are essentially cured. This is one of the biggest reasons that effective diagnosis is of utmost
importance in the United States. Once a celiac has been on the GFD for a period of time, previously
increased mortality often returns to that of the normal rate, the intestinal lining heals, and negative
symptoms related to gluten consumption cease (Biagi, 2010; NIH, 2008).
Therefore, much depends on if a celiac can adhere to the GFD with a high rate of success. If a
celiac cannot strictly comply with a lifelong GFD, he/she faces the risk of developing further health
complications, including osteoporosis, arthritis, infertility, anemia, depression, certain cancers (NIH,
2008). These complications may have a significant effect on health care costs as well as patient quality
of life. For example, in 2010 medical costs associated with lymphoma, a cancer that has increased
incidence in CD patients, totaled $12 billion nationally (Pruessner 1998; NIH News, 2011).
This research analyzed previously un-compared perspectives of individuals from diverse
backgrounds to discover a wide range of solutions to and a more accurate picture of the barriers that
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celiacs in the United States face. Currently, there is not a great deal of research being done on CD in
the United States, an issue potentially related to low awareness. While the body of research has grown
in the past two decades, there is still a long way to go. In addition, most of the research being done
addresses celiac disease from a medical perspective, studying topics such as treatment, pathology,
and clinical presentation. While this research is valuable and needed, CD diagnosis and treatment is
also an issue with strong social components. Little research has been performed in this area and this is
a void that I have sought to address with my study.
Findings were significant because they have implications for how we will approach celiac disease
in the United States in the future. During this project, many tangible and addressable barriers were
identified. These barriers also had widespread relatability and applicability to celiacs across the United
States. Main barriers identified fell into three main categories: 1.) Education and Awareness, 2.) Lack of
Supportive Social Environment, and 3.) Governmental Regulation.
While education and awareness was an issue that significantly impacted all segments of the
population, the lack of education and awareness among medical professionals seemed to be the most
damaging to effective celiac diagnosis in the United States. However, the importance of awareness and
education among members of the food industry, among school professionals, public policymakers, and
the general public also cannot be underemphasized.
Lack of a supportive social environment was the barrier that most affects celiac patient quality of
life in the United States. Because celiac quality of life and future health greatly depends on the patient’s
ability to adhere to the GFD, it follows that an environment that enables the celiac to comply with the
GFD would be crucial to patient wellbeing. Currently issues such as cross-contamination in restaurants,
low availability and increased cost of gluten-free products, having to identify oneself as “different,” and
the negative symptoms that come with accidental gluten consumption are common barriers related to
the social environment that celiacs face in the United States.
Governmental regulation also plays a significant role in celiac patient wellbeing. In the United
States, legislation in this area is extremely limited. As of this writing, there are no clear guidelines for
what “gluten-free” means. As discussed in the interview with the U.S. awareness organization
representative, Food and Drug Administration regulation of the term "gluten-free" and the setting of
standards for the maximum concentration of gluten that can be found in a product, would increase
general awareness for celiac disease as well as food industry recognition of celiac issues.
Proposed Solutions
T a b le 2. T o p S o lu tio n s D is c u s s e d d u rin g In te r v ie w s
B y P a tie n ts :

B y M e d ic a l P ro fe s s io n a ls :

B y A w a re n e s s O rg a n iz a tio n
R e p r e s e n ta tiv e s :

•

•

Im p r o v e m e n t o f s o c ia l s itu a tio n fo r
c e lia c s , e s p e c ia lly g re a te r
a c c e s s ib ility to g lu te n - fr e e fo o d s
w h e n e a tin g o u ts id e th e h o m e
R e s e a rc h in to e a rly a n d e ffe c tiv e
d ia g n o s is a n d tre a tm e n t fo r C D

• C e lia c s s h o u ld e d u c a te o th e rs b y
ta lk in g to th e m a b o u t C D to ra is e
g e n e r a l a w a re n e s s

• E n h a n c in g m e d ic a l c u rr ic u la a c ro s s
a ll s p e c ia ltie s w ith to p ic s re la te d to
CD.
• C o n tin u in g e d u c a tio n th a t ta rg e ts
m e d ic a l p ro fe s s io n a ls o f m a n y

• F D A re g u la tio n o f th e te rm “ g lu te n fr e e ” - s e t c le a r s ta n d a rd s
• N a tio n a l d a ta b a s e a n d d a ta
c o lle c tio n s y s te m

• C o n s u m e r -d r iv e n a w a re n e s s e ffo rts

• G r e a te r c o o p e r a tio n b e tw e e n
a w a re n e s s o rg a n iz a tio n s a n d
g o v e rn m e n t

• G r e a te r s ta n d a r d iz a tio n fo r c e lia c
te s tin g a n d d ia g n o s tic p ro c e d u r e s

• P e e r -to - p e e r e d u c a tio n a l e v e n ts fo r
m e d ic a l p ro fe s s io n a ls

d is c ip lin e s
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While many possible solutions were suggested by interviewees, one response that echoed
throughout the interviews was the call for a multi-disciplinary approach that involves medical
professionals from a variety of fields, patients, and industry professionals. Because the signs and
symptoms of CD are often nonspecific and affect many systems within the body (Pruessner, 1998;
Catassi, 2008), a team approach to celiac disease case-finding is required.
The U.S. general care provider also had a very interesting and sustainable approach to celiac
disease awareness. He explained that change must be driven by the demand of the celiac population
in the United States. He continued by saying that businesses will listen to consumer demand, so
combining marketing of GF products with education about CD symptoms would be a profitable way for
companies to help their celiac client base to grow through raising awareness about celiac disease.
Limitations of the study design
Because of the small sample size (n=12), the majority of the data was qualitative, rather than
quantitative. The research team was also very small and time constraints were a significant limitation.
There were also limitations in comparing the views of the medical professionals from the United States
States (a general care provider and registered dietitian) to those from Italy (two gastroenterologists)
because of the difference in professional position. An improved research design is planned for future
work. It was also somewhat challenging to compare perspectives of different medical professionals
because the medicals systems in which the respective professionals work are so different.
Problems that may have occurred that affected the outcome
Many people were on the annual vacation period taken by many in Italy. Medical professionals,
especially, were difficult to get in touch with. Some interviews were necessary to conduct by distance
but were somewhat complicated by the language barrier.
Interviewees in Italy were all from a similar geographic location (Lombardia/ Milan) and
interviewees from the U.S. were more spread out, from multiple states (including Midwestern and West
Coast regions). Interviewees were not selected randomly, so this affected their representativeness of
the entire population. Volunteer bias may have also affected the results. It is possible that patients in
Italy and the U.S. who had a bad experience with celiac disease would probably be less likely to offer
to talk about it.

Strengths of the study
The research was well funded through the Expand Your Education (EYE) and Undergraduate
Special Opportunities in Artistry and Research (USOAR) grants. Another strength of this study was
that it was primary research. Being able to travel to the site and talk to people in person was a vital
component of the research from a cultural standpoint, especially in Italy. This also helped to minimize
information being lost in translation. An additional strength was that this study explored previously un
compared perspectives, filling an information gap in currently available research. Diversity among
interviewees was also a strength: interviewees provided a broad range of perspectives for a more
complete picture of barriers to patient diagnosis and wellbeing in the United States. Interviews came
from a variety different life situations, backgrounds, and nationality. Another strength was the
multidisciplinary approach of study design: drawing from nutrition, public health, anthropology,
epidemiology, sociology, and medical perspectives.
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Areas for Further Research
While I did succeed in answering the research questions that this study centered on, in some
ways, I conclude this project with more questions than I started with about the social situation
surrounding CD. One of the most interesting areas for future research was the impact that awareness
organizations can have. While all interviewees agreed quality of life for.celiacs living in Italy is currently
high, multiple interviewees reported that this has not always been the case. They reported that the
situation for celiacs in Italy has significantly improved in the last 10-12 years, a change with a start-time
that correlates to around the time AIC restructured in 1999 to become a federation of regional
associations. In the years after that, celiac census data also started increasing in availability
(Associazione Italiana Celiachia). I believe there is a potential connection between the restructuring of
the organization for a more nationally unified approach and the current high quality of care that celiacs
receive in Italy. There are many areas for future research into this topic of celiac disease awareness
and social structure including:
• What has changed in Italy over the past 10 years to cause this significant increase in
celiac awareness?
• How do the awareness organizations in the United States function and cooperate with the
government versus those in European countries as it relates to celiac awareness and
quality of care?
• How is training about celiac disease integrated into medical curricula in Italy and other
European countries versus that of the United States?
• What is the correlation between United States post-diagnosis patient support/education
and degree of compliance with the GFD?
J. Lessons Learned & Conclusion
As I boarded the plane to fly out of O’Hare International Airport on July 23, 2012,1was both
nervous and excited to be leaving the country for the first time. Now that I have completed my
research, I realize that I have changed and grown a great deal. I feel that the world is a much bigger
place because the situation I studied in Italy is just one country’s approach to celiac disease and there
are hundreds of countries in the world. I also feel that the world is smaller in some respects. At one
point traveling to Italy for research seemed so far out of reach, but now that I have been able to do this,
I feel more confident in my potential to accomplish even greater things in my field in the future.
Being able to conduct this research has impacted me in more ways than I can count. To start, it has
given me a broader understanding of cultural differences and diversity. This project has also given me
more understanding of celiac disease-related issues and more respect for the resilience and strength
of celiac patients. I also have gained invaluable experience working with professionals in my future
field. Through this, I have grown significantly in the skills of diplomacy, communication, negotiation,
and assertiveness. I have learned an incredible amount about grant proposal and professional writing,
institutional review board procedures, ethics in research with human subjects, patient confidentiality
issues, interviewing, and interacting with people who come from different cultures. This project has
also strengthened my skills in professional conduct, public speaking, and organization.
Through completing this project, I have become even more sure in my chosen career path.
Conducting this research has helped me to reaffirm where my passions are: working and talking oneon-one with people and helping individuals with food allergies and autoimmune disorders. Some of the
experiences of this project also helped me to decide that I want to pursue a master’s degree with an
emphasis in clinical and counseling psychology. Visiting Italy also helped me realize how much I love
to travel, see new places, and experience different cultures. It has also broadened my curiosity about
other topics related to celiac disease I would like to research further. Overall, I feel that this project has
opened me up to a whole new world of possibilities, including traveling to other countries to explore
other cultures, and increased my capacity to overcome challenges, ask questions, and search for
solutions.
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